We'll be OK once RECAF is partnered with Abbott's PSA test, and considering how long Abbott has had RECAF, surely that won't be too much longer. Terry mentioned revenues in the ballpark of 2-3 dollars per test, so that would be a considerable amount.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.